---
title: "CH BIOTECH SER announced its interim results, with a loss attributable to shareholders of HKD 32.06 million, a year-on-year narrowing of 59.95%"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/254852505.md"
description: "CH BIOTECH SER announced its mid-term results for 2025, with revenue of HKD 38.872 million, a year-on-year increase of 19.79%; the loss attributable to shareholders was HKD 32.006 million, a year-on-year narrowing of 59.95%; the loss per share was HKD 0.033. The improvement in loss was mainly due to the successful implementation of cost control measures, an increase in gross profit margin, a reduction in administrative expenses, and the receipt of approximately HKD 13.7 million in insurance compensation income"
datetime: "2025-08-27T15:12:03.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/254852505.md)
  - [en](https://longbridge.com/en/news/254852505.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/254852505.md)
---

# CH BIOTECH SER announced its interim results, with a loss attributable to shareholders of HKD 32.06 million, a year-on-year narrowing of 59.95%

According to the Zhitong Finance APP, CH BIOTECH SER (08037) announced its interim results for 2025, with revenue of HKD 38.872 million, a year-on-year increase of 19.79%; the loss attributable to shareholders narrowed to HKD 32.006 million, a decrease of 59.95% year-on-year; the loss per share was HKD 0.033.

The announcement stated that the main reason for the improvement in loss was the successful implementation of cost control measures by the company, leading to an increase in gross profit margin and a reduction in administrative expenses, as well as compensation income of approximately HKD 13.7 million received from insurance claims for damages caused by heavy rains at construction sites in Hainan in 2024

### Related Stocks

- [08037.HK](https://longbridge.com/en/quote/08037.HK.md)

## Related News & Research

- [Oil little changed as traders await breakthrough in US.-Iran negotiations](https://longbridge.com/en/news/286925961.md)
- [COSCO Shipping Development acquires 10 bulk carriers under construction in connected transaction](https://longbridge.com/en/news/287235721.md)
- [Kelun-Biotech says sac-TMT beats chemotherapy in Phase III first-line TNBC PFS](https://longbridge.com/en/news/287235165.md)
- [The 'Elon Musk Effect' Could Send SpaceX Stock Into Wild Swings After IPO Even If Starlink Makes 'Billions' In Profit, Warns Expert](https://longbridge.com/en/news/286923494.md)
- [Haier Smart Home files HKEX next-day return, discloses RMB 20.69 per-share buyback](https://longbridge.com/en/news/287216971.md)